Clinical Trials Directory

Trials / Completed

CompletedNCT06338956

Optimal Attained LDL-Cholesterol Levels in Patients Who Achieved ≥50% LDL Reduction After PCI

Status
Completed
Phase
Study type
Observational
Enrollment
135,877 (actual)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

For the management of low-density lipoprotein-cholesterol (LDL-C), some guidelines recommend initial statin treatment with high-intensity statins to achieve at least a 50% reduction in LDL-C levels. High-intensity or maximally tolerated intensity can be maintained without a target goal. However, the European guideline recommends less than 55 mg/dL of LDL-C after PCI.

Detailed description

To investigate the Optimal Attained LDL-C Levels in Patients Who Achieved ≥50% LDL-C Reduction After PCI.

Conditions

Interventions

TypeNameDescription
DRUGLDL reduction therapyLDL reduction therapy

Timeline

Start date
2024-01-01
Primary completion
2024-12-31
Completion
2025-05-15
First posted
2024-04-01
Last updated
2025-05-21

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT06338956. Inclusion in this directory is not an endorsement.